Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Comorbidities Are Associated with Altered Health Services Use in Multiple Sclerosis: A Prospective Cohort Study.

McKay KA, Marrie RA, Fisk JD, Patten SB, Tremlett H.

Neuroepidemiology. 2018;51(1-2):1-10. doi: 10.1159/000488799. Epub 2018 May 15.

PMID:
29763935
2.

Diagnoses of Depression and Anxiety Versus Current Symptoms and Quality of Life in Multiple Sclerosis.

Marrie RA, Patten SB, Berrigan LI, Tremlett H, Wolfson C, Warren S, Leung S, Fiest KM, McKay KA, Fisk JD; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Int J MS Care. 2018 Mar-Apr;20(2):76-84. doi: 10.7224/1537-2073.2016-110.

3.

Psychiatric comorbidity is associated with disability progression in multiple sclerosis.

McKay KA, Tremlett H, Fisk JD, Zhang T, Patten SB, Kastrukoff L, Campbell T, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis.

Neurology. 2018 Apr 10;90(15):e1316-e1323. doi: 10.1212/WNL.0000000000005302. Epub 2018 Mar 9.

PMID:
29523642
4.

Physical activity and disability outcomes in multiple sclerosis: A systematic review (2011-2016).

Charron S, McKay KA, Tremlett H.

Mult Scler Relat Disord. 2018 Feb;20:169-177. doi: 10.1016/j.msard.2018.01.021. Epub 2018 Feb 2. Review.

PMID:
29414293
5.

Drug exposure and the risk of multiple sclerosis: A systematic review.

Yong HY, McKay KA, Daley CGJ, Tremlett H.

Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):133-139. doi: 10.1002/pds.4357. Epub 2017 Dec 6. Review.

PMID:
29210147
6.

Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.

Kowalec K, McKay KA, Patten SB, Fisk JD, Evans C, Tremlett H, Marrie RA; CIHR Team in Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Neurology. 2017 Dec 12;89(24):2455-2461. doi: 10.1212/WNL.0000000000004716. Epub 2017 Nov 8.

PMID:
29117961
7.

Disease-Modifying Therapies and Adherence in Multiple Sclerosis: Comparing Patient Self-Report with Pharmacy Records.

McKay KA, Evans C, Fisk JD, Patten SB, Fiest K, Marrie RA, Tremlett H.

Neuroepidemiology. 2017;48(3-4):124-130. doi: 10.1159/000477771. Epub 2017 Jul 7.

PMID:
28683461
8.

From bugs to brains: The microbiome in neurological health.

McKay KA, Kowalec K, Brinkman F, Finlay BB, Horwitz M, Manges AR, Osborne L, Tremlett H.

Mult Scler Relat Disord. 2017 Feb;12:1-3. doi: 10.1016/j.msard.2016.12.007. Epub 2016 Dec 18.

PMID:
28283098
9.

Genetic variation associated with the occurrence and progression of neurological disorders.

Little J, Barakat-Haddad C, Martino R, Pringsheim T, Tremlett H, McKay KA, van Lieshout P, Walsh SJ, Gomes J, Krewski D.

Neurotoxicology. 2017 Jul;61:243-264. doi: 10.1016/j.neuro.2016.09.018. Epub 2016 Oct 3. Review.

PMID:
27713094
10.

Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study.

McKay KA, Tremlett H, Patten SB, Fisk JD, Evans C, Fiest K, Campbell T, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Mult Scler. 2017 Apr;23(4):588-596. doi: 10.1177/1352458516657440. Epub 2016 Jul 11.

11.

Fatigue and Comorbidities in Multiple Sclerosis.

Fiest KM, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, McKay KA, Berrigan LI, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Int J MS Care. 2016 Mar-Apr;18(2):96-104. doi: 10.7224/1537-2073.2015-070.

12.

Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.

McKay KA, Jahanfar S, Duggan T, Tkachuk S, Tremlett H.

Neurotoxicology. 2017 Jul;61:189-212. doi: 10.1016/j.neuro.2016.03.020. Epub 2016 Apr 1. Review.

PMID:
27045883
13.

A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada.

McKay KA, Tremlett H, Zhu F, Kastrukoff L, Marrie RA, Kingwell E.

Eur J Neurol. 2016 Jun;23(6):1093-100. doi: 10.1111/ene.12990. Epub 2016 Mar 15.

14.

Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity.

Berrigan LI, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, Fiest KM, McKay KA, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Neurology. 2016 Mar 9. pii: 10.1212/WNL.0000000000002564. [Epub ahead of print]

15.

Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes.

Zhornitsky S, McKay KA, Metz LM, Teunissen CE, Rangachari M.

Mult Scler Relat Disord. 2016 Jan;5:53-65. doi: 10.1016/j.msard.2015.10.005. Epub 2015 Oct 19. Review.

PMID:
26856944
16.

Comorbidity is associated with pain-related activity limitations in multiple sclerosis.

Fiest KM, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, McKay KA, Berrigan L, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Mult Scler Relat Disord. 2015 Sep;4(5):470-476. doi: 10.1016/j.msard.2015.07.014. Epub 2015 Jul 29.

17.

Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study.

McKay KA, Tremlett H, Fisk JD, Patten SB, Fiest K, Berrigan L, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Mult Scler. 2016 Apr;22(5):685-93. doi: 10.1177/1352458515599073. Epub 2015 Aug 5.

18.

Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review.

McKay KA, Kwan V, Duggan T, Tremlett H.

Biomed Res Int. 2015;2015:817238. doi: 10.1155/2015/817238. Epub 2015 Jan 31. Review.

19.

The systematic search for risk factors in multiple sclerosis.

McKay KA, Tremlett H.

Lancet Neurol. 2015 Mar;14(3):237-8. doi: 10.1016/S1474-4422(15)70015-3. Epub 2015 Feb 4. No abstract available.

PMID:
25662899
21.
22.

Hepatic lesions and bacterial changes in mice during infection of Fusobacterium necrophorum.

Garcia MM, Charlton KM, McKay KA.

Can J Microbiol. 1977 Oct;23(10):1465-77.

PMID:
922598
23.
24.

Characterization of endotoxin from Fusobacterium necrophorun.

Garcia MM, Charlton KM, McKay KA.

Infect Immun. 1975 Feb;11(2):371-9.

25.

Results of a preliminary trial with Sphaerophorus necrophorus toxoids to control liver abscesses in feedlot cattle.

Garcia MM, Dorward WJ, Alexander DC, Magwood SE, McKay KA.

Can J Comp Med. 1974 Jul;38(3):222-6.

26.

Assessment of various adjuvants in sphaerophorus necrophorus toxoids.

Alexander DC, Garcia MM, McKay KA.

Can Vet J. 1973 Oct;14(10):247-51. No abstract available.

27.

A satisfactory medium and technique for the mass cultivation of Sphaerophorus necrophorus.

Garcia MM, McKay KA.

Can J Microbiol. 1973 Feb;19(2):296-8. No abstract available.

PMID:
4121315
28.

Application of immunofluorescence to studies on the ecology of Sphaerophorus necrophorus.

Garcia MM, Neil DH, McKay KA.

Appl Microbiol. 1971 May;21(5):809-14.

29.

Pathogenic microorganisms in soil: an old problem in a new perspective.

Garcia MM, McKay KA.

Can J Comp Med. 1970 Apr;34(2):105-10.

30.

A stable L-form of Haemophilus pleuropneumoniae.

Neil DH, Garcia MM, McKay KA.

Can J Comp Med. 1970 Jan;34(1):50-8.

31.
32.

On the growth and survival of Clostridium septicum in soil.

Garcia MM, McKay KA.

J Appl Bacteriol. 1969 Sep;32(3):362-70. No abstract available.

PMID:
4904967
33.

Glasser's disease of swine produced by the intracheal inoculation of haemophilus suis.

Neil DH, McKay KA, L'Ecuyer C, Corner AH.

Can J Comp Med. 1969 Jul;33(3):187-93.

34.

The possibility of producing tuberculin sensitivity by feeding poultry litter.

Carrière JA, Alexander DC, McKay KA.

Can Vet J. 1968 Aug;9(8):178-85. No abstract available.

35.

Bacteriological studies of poultry litter fed to livestock.

Alexander DC, Carrière JA, McKay KA.

Can Vet J. 1968 Jun;9(6):127-31. No abstract available.

36.

The demonstration of a single species of an unclassified bacterium in five cases of bovine lymphosarcoma.

McKay KA, Neil DH, Corner AH.

Growth. 1967 Dec;31(4):357-68. No abstract available.

PMID:
4172379
37.

Microbial persistence and latent infection.

McKay KA, Corner AH, Byrne JL.

Can J Comp Med Vet Sci. 1967 Oct;31(10):256-9. No abstract available.

38.

Production of an enzootic-like pneumonia in pigs with "protoplasts" of Haemophilus parainfluenzae.

McKay KA, Abelseth MK, Vandreumel AA.

Nature. 1966 Oct 22;212(5060):359-60. No abstract available.

PMID:
4291148
39.

THE RESULTS OF SENSITIVITY TESTS ON ANIMAL PATHOGENS CONDUCTED OVER THE PERIOD 1956-1963.

MCKAY KA, RUHNKE HL, BARNUM DA.

Can Vet J. 1965 May;6(5):103-11. No abstract available.

41.

Studies on Colibacillosis of Calves. III. The Experimental Reproduction of Colibacillosis.

Gay CC, McKay KA, Barnum DA.

Can Vet J. 1964 Dec;5(12):314-25. No abstract available.

43.

Studies on Colibacillosis of Calves. I. The Antibody Acquired by Calves as the Result of Vaccination of the Dam.

Gay CC, McKay KA, Barnum DA.

Can Vet J. 1964 Oct;5(10):248-61. No abstract available.

44.

Colibacillosis of Calves in Ontario. II. The Association of Certain Serotypes of Escherichia Coli with Calf Scours.

Gossling J, McKay KA, Barnum DA.

Can Vet J. 1964 Sep;5(9):220-8. No abstract available.

45.

Colibacillosis of Calves in Ontario: I. A Serological Study of Escherichia Coli Strains.

Gossling J, McKay KA, Barnum DA.

Can Vet J. 1964 Jul;5(7):151-9. No abstract available.

46.

A Clinical and Laboratory Evaluation of a New Sulfonamide.

Archibald J, McKay KA.

Can Vet J. 1964 Feb;5(2):30-5. No abstract available.

47.

EXPERIMENTAL ENTERITIS PRODUCED IN DOGS BY ESCHERICHIA COLI ENDOTOXIN.

MULLENS JE, MCKAY KA, JUBB KV.

Can J Surg. 1964 Jan;7:79-88. No abstract available.

PMID:
14106542
48.

Clostridial infection of the liver in the canine after ligation of the hepatic artery.

COBB LM, McKAY KA, ARCHIBALD J, MARKOWITZ J.

Can J Surg. 1962 Oct;5:450-60. No abstract available.

PMID:
14021828
49.

A bacteriological study of the liver of the normal dog.

COBB LM, McKAY KA.

J Comp Pathol. 1962 Jan;72:92-6. No abstract available.

PMID:
13880034
50.

Streptobacillus Moniliformis Infection in a Dog.

Ditchfield J, Lord LH, McKay KA.

Can Vet J. 1961 Dec;2(12):457-9. No abstract available.

Supplemental Content

Loading ...
Support Center